CRO is a need-to know practice in pharmaceutical marketing today; but information is not always easy to find. This second edition of Kalorama’s best-selling look at the clinical contract research industry provides the key information competitors need to navigate the complexities and costs of clinical research in the drug development process. In addition to a comprehensive discussion of the market and regulatory environment, the report details:
- the size and nature of the drug research pipeline,
- the size and growth of R&D spending in- and out-of-house,
- the size of the CRO market by phase and by player type (CROs, academic centers, analytical laboratories, and SMOs), and
- provides market share information on the leading players.